Paragonix Technologies SherpaPak® Improves 1-Year Survival in Heart Transplant Patients in Real-World Study

GUARDIAN Registry data presented at ISHLT 2022 has shown a 72% reduction (p=0.005) in Severe PGD (primary graft dysfunction) and a 39% reduction (p=0.03) in Mechanical Circulatory Support, in addition…

Continue ReadingParagonix Technologies SherpaPak® Improves 1-Year Survival in Heart Transplant Patients in Real-World Study

Paragonix Technologies Hosting ISHLT Industry Symposium “Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport”

Paragonix medical devices featured in multiple seminars and posters at Boston’s ISHLT 2022 Annual Meeting outcomes CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, is presenting new research…

Continue ReadingParagonix Technologies Hosting ISHLT Industry Symposium “Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport”

Paragonix Technologies Presenting New Organ Preservation Research at the International Society of Heart and Lung Transplantation 2022 Annual Meeting

Paragonix medical devices featured in multiple seminars and posters at Boston’s ISHLT 2022 Annual Meeting outcomes CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, is presenting new research…

Continue ReadingParagonix Technologies Presenting New Organ Preservation Research at the International Society of Heart and Lung Transplantation 2022 Annual Meeting

Paragonix SherpaPak featured in KMTV News segment “Glenwood man is first-ever SherpaPak heart transplant recipient”

https://youtu.be/Ja5MzXpjbLA From KMTV News Now Omaha OMAHA, Neb. (KMTV) — Looking at him, you might not know Tim Hagen is one in 7.9 billion. "When they found the cancer, the…

Continue ReadingParagonix SherpaPak featured in KMTV News segment “Glenwood man is first-ever SherpaPak heart transplant recipient”

University of Virginia Medical Center Completes First Successful Transplant Using the Paragonix SherpaPak® Cardiac Transport System

CAMBRIDGE, MASSACHUSETTS – February 8, 2022 – Paragonix Technologies announced the first successful heart transplant at the University of Virginia Medical Center using it’s SherpaPak Cardiac Transport System (CTS). The…

Continue ReadingUniversity of Virginia Medical Center Completes First Successful Transplant Using the Paragonix SherpaPak® Cardiac Transport System

Paragonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case

Device enables donor lungs to safely travel unprecedented distance of 4,788 Miles with a total ischemic time of over 13 hours CAMBRIDGE, MASSACHUSETTS – Feb. 2, 2021 – Paragonix Technologies announces…

Continue ReadingParagonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case

Paragonix Technologies Announces Launch of the Paragonix Web Portal, Providing Users Access to Critical Organ Preservation Data

Real-time, centralized, secure coordination and data for transplant teams to facilitate the optimization of the donation and transplantation process CAMBRIDGE, MASSACHUSETTS – January 4, 2022 – Paragonix Technologies, Inc. is announcing…

Continue ReadingParagonix Technologies Announces Launch of the Paragonix Web Portal, Providing Users Access to Critical Organ Preservation Data

Paragonix Announces First-in-Human use of LIVERguard™ Donor Liver Preservation System by Mayo Clinic

CAMBRIDGE, MASSACHUSETTS – Dec. 15, 2021 –  Paragonix Technologies, the leading hypothermic cardiothoracic organ preservation provider, announced today the first-in-human clinical use of the only FDA cleared cold storage device…

Continue ReadingParagonix Announces First-in-Human use of LIVERguard™ Donor Liver Preservation System by Mayo Clinic

First-in-Human Use of Investigational NRP-DCD Method Using Paragonix SherpaPak by University of Nebraska Medical Center

CAMBRIDGE, MASSACHUSETTS – December 1, 2021 – Paragonix Technologies, the leading hypothermic donor organ preservation provider, announced the first-in-human clinical use of the investigational NRP-DCD Method by the University of Nebraska…

Continue ReadingFirst-in-Human Use of Investigational NRP-DCD Method Using Paragonix SherpaPak by University of Nebraska Medical Center

Paragonix Technologies Announces Milestone of 1,000 Preserved Donor Heart Transports

More donor hearts safely traveling long distances with the Paragonix SherpaPak Cardiac Transport SystemCAMBRIDGE, MASSACHUSETTS – November 16, 2021 – Paragonix Technologies, Inc. is announcing a major milestone of 1,000 preserved…

Continue ReadingParagonix Technologies Announces Milestone of 1,000 Preserved Donor Heart Transports